Please enable JavaScript to continue using this application.

Compare $ABEO vs $CYPH | Chartloom

Compare

$ABEO vs $CYPH

Abeona Therapeutics Inc · Cypherpunk Technologies Inc

ABEO

Abeona Therapeutics Inc

CYPH

Cypherpunk Technologies Inc

Compare $ABEO vs $CYPH

Comparing Abeona Therapeutics Inc and Cypherpunk Technologies Inc

ABEOAbeona Therapeutics Inc

CYPHCypherpunk Technologies Inc

ABEOAbeona Therapeutics Inc

Market cap

$282M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.20x

Rev growth (TTM)

6280.0%

YTD performance

-7.0%

52W performance

-10.8%

FCF yield

-29.0%

CYPHCypherpunk Technologies Inc

Market cap

$313M

P/E (TTM)

—

Forward P/E (NTM)

26.20x

Forward P/S (NTM)

6.06x

Rev growth (TTM)

—

YTD performance

160.2%

52W performance

292.0%

FCF yield

-11.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABEO

CYPH

Detailed metrics comparison

ABEO

Abeona Therapeutics Inc

CYPH

Cypherpunk Technologies Inc

Market Cap

ABEO$282M

CYPH$313M

Enterprise Value

ABEO$240M

CYPH$305M

Price

ABEO$4.94

CYPH$2.94

P/E Ratio

ABEON/A

CYPHN/A

P/S Ratio

ABEO11.03x

CYPH217.68x

EV/Sales

ABEO9.42x

CYPH0.00x

EV/EBITDA

ABEO3.95x

CYPH0.00x

P/B Ratio

ABEO2.25x

CYPH2.34x

P/FCF Ratio

ABEON/A

CYPHN/A

EV/FCF

ABEO-2.95x

CYPH-8.83x

PEG Ratio

ABEON/A

CYPHN/A

Forward P/E (NTM)

ABEON/A

CYPH26.20x

Forward P/S (NTM)

ABEO3.20x

CYPH6.06x

Revenue (TTM)

ABEO$26M

CYPH$0

Revenue Growth (YoY)

ABEO6280.0%

CYPHN/A

Forward Rev Growth

ABEO131.0%

CYPH155.2%

Gross Margin (TTM)

ABEO67.1%

CYPH0.0%

Operating Margin (TTM)

ABEO0.0%

CYPH0.0%

EBITDA Margin (TTM)

ABEO-316.6%

CYPH0.0%

Net Margin (TTM)

ABEO-246.4%

CYPH0.0%

FCF Margin (TTM)

ABEO-319.5%

CYPHN/A

Net Income (TTM)

ABEO$-63M

CYPH$-877K

FCF (TTM)

ABEO$-82M

CYPH$-35M

EPS (TTM)

ABEO-$1.10

CYPH-$0.00

ROE (TTM)

ABEO-4169.0%

CYPH-92.0%

ROA (TTM)

ABEO-3036.0%

CYPH-87.0%

ROIC (TTM)

ABEO-3719.0%

CYPH-92.0%

Cash

ABEO$56M

CYPH$8M

Debt

ABEO$15M

CYPH$0

Net Cash/Debt

ABEO$41M

CYPH$8M

Current Ratio (TTM)

ABEO6.63x

CYPH79.19x

Quick Ratio (TTM)

ABEO6.32x

CYPH78.88x

Debt/Equity (TTM)

ABEO0.12x

CYPH0.00x

Debt/Assets (TTM)

ABEO0.0%

CYPH0.0%

Interest Coverage (TTM)

ABEON/A

CYPHN/A

Net Debt/EBITDA (TTM)

ABEO0.00x

CYPH0.00x

Beta

ABEO1.45

CYPH1.13

52W Performance

ABEO-10.8%

CYPH292.0%

YTD Performance

ABEO-7.0%

CYPH160.2%

% from 52W High

ABEO-35.4%

CYPH-29.8%

% from 52W Low

ABEO23.5%

CYPH648.1%

Asset Turnover (TTM)

ABEO0.13x

CYPH0.02x

FCF Yield (TTM)

ABEO-29.0%

CYPH-11.1%

Earnings Yield (TTM)

ABEO-22.3%

CYPH-0.3%

Dividend Yield (TTM)

ABEON/A

CYPHN/A

Rule of 40

ABEO5,960.5

CYPH0.0

EV/GP/RG

ABEO0.04

CYPHN/A

Ticker research

View ABEO research View CYPH research

Metric	ABEO Abeona Therapeutics Inc	CYPH Cypherpunk Technologies Inc
Market & Valuation
Market Cap	$282M	$313M
Enterprise Value	$240M	$305M
Price	$4.94	$2.94
P/E Ratio	N/A	N/A
P/S Ratio	11.03x	217.68x
EV/Sales	9.42x	0.00x
EV/EBITDA	3.95x	0.00x
P/B Ratio	2.25x	2.34x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.95x	-8.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	26.20x
Forward P/S (NTM)	3.20x	6.06x
Revenue & Growth
Revenue (TTM)	$26M	$0
Revenue Growth (YoY)	6280.0%	N/A
Forward Rev Growth	131.0%	155.2%
Profitability
Gross Margin (TTM)	67.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-316.6%	0.0%
Net Margin (TTM)	-246.4%	0.0%
FCF Margin (TTM)	-319.5%	N/A
Net Income (TTM)	$-63M	$-877K
FCF (TTM)	$-82M	$-35M
EPS (TTM)	-$1.10	-$0.00
ROE (TTM)	-4169.0%	-92.0%
ROA (TTM)	-3036.0%	-87.0%
ROIC (TTM)	-3719.0%	-92.0%
Financial Health
Cash	$56M	$8M
Debt	$15M	$0
Net Cash/Debt	$41M	$8M
Current Ratio (TTM)	6.63x	79.19x
Quick Ratio (TTM)	6.32x	78.88x
Debt/Equity (TTM)	0.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	1.13
52W Performance	-10.8%	292.0%
YTD Performance	-7.0%	160.2%
% from 52W High	-35.4%	-29.8%
% from 52W Low	23.5%	648.1%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.02x
FCF Yield (TTM)	-29.0%	-11.1%
Earnings Yield (TTM)	-22.3%	-0.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,960.5	0.0
EV/GP/RG	0.04	N/A
Ticker research	View ABEO research	View CYPH research

Valuation

P/S Ratio

ABEO

11.03x

CYPH

217.68x

EV/FCF

CYPH

-8.83x

ABEO

-2.95x

Growth & revenue

Revenue Growth TTM

ABEO

6280.0%

Forward Revenue Growth

CYPH

155.2%

ABEO

131.0%

Profitability & performance

Gross Margin

ABEO

67.1%

CYPH

0.0%

ROE

CYPH

-92.0%

ABEO

-4169.0%

FCF Yield %

CYPH

-11.1%

ABEO

-29.0%

52-Week Performance

CYPH

292.0%

ABEO

-10.8%

Detailed metrics comparison

ABEO

Abeona Therapeutics Inc

CYPH

Cypherpunk Technologies Inc

Market Cap

ABEO$282M

CYPH$313M

Enterprise Value

ABEO$240M

CYPH$305M

Price

ABEO$4.94

CYPH$2.94

P/E Ratio

ABEON/A

CYPHN/A

P/S Ratio

ABEO11.03x

CYPH217.68x

EV/Sales

ABEO9.42x

CYPH0.00x

EV/EBITDA

ABEO3.95x

CYPH0.00x

P/B Ratio

ABEO2.25x

CYPH2.34x

P/FCF Ratio

ABEON/A

CYPHN/A

EV/FCF

ABEO-2.95x

CYPH-8.83x

PEG Ratio

ABEON/A

CYPHN/A

Forward P/E (NTM)

ABEON/A

CYPH26.20x

Forward P/S (NTM)

ABEO3.20x

CYPH6.06x

Revenue (TTM)

ABEO$26M

CYPH$0

Revenue Growth (YoY)

ABEO6280.0%

CYPHN/A

Forward Rev Growth

ABEO131.0%

CYPH155.2%

Gross Margin (TTM)

ABEO67.1%

CYPH0.0%

Operating Margin (TTM)

ABEO0.0%

CYPH0.0%

EBITDA Margin (TTM)

ABEO-316.6%

CYPH0.0%

Net Margin (TTM)

ABEO-246.4%

CYPH0.0%

FCF Margin (TTM)

ABEO-319.5%

CYPHN/A

Net Income (TTM)

ABEO$-63M

CYPH$-877K

FCF (TTM)

ABEO$-82M

CYPH$-35M

EPS (TTM)

ABEO-$1.10

CYPH-$0.00

ROE (TTM)

ABEO-4169.0%

CYPH-92.0%

ROA (TTM)

ABEO-3036.0%

CYPH-87.0%

ROIC (TTM)

ABEO-3719.0%

CYPH-92.0%

Cash

ABEO$56M

CYPH$8M

Debt

ABEO$15M

CYPH$0

Net Cash/Debt

ABEO$41M

CYPH$8M

Current Ratio (TTM)

ABEO6.63x

CYPH79.19x

Quick Ratio (TTM)

ABEO6.32x

CYPH78.88x

Debt/Equity (TTM)

ABEO0.12x

CYPH0.00x

Debt/Assets (TTM)

ABEO0.0%

CYPH0.0%

Interest Coverage (TTM)

ABEON/A

CYPHN/A

Net Debt/EBITDA (TTM)

ABEO0.00x

CYPH0.00x

Beta

ABEO1.45

CYPH1.13

52W Performance

ABEO-10.8%

CYPH292.0%

YTD Performance

ABEO-7.0%

CYPH160.2%

% from 52W High

ABEO-35.4%

CYPH-29.8%

% from 52W Low

ABEO23.5%

CYPH648.1%

Asset Turnover (TTM)

ABEO0.13x

CYPH0.02x

FCF Yield (TTM)

ABEO-29.0%

CYPH-11.1%

Earnings Yield (TTM)

ABEO-22.3%

CYPH-0.3%

Dividend Yield (TTM)

ABEON/A

CYPHN/A

Rule of 40

ABEO5,960.5

CYPH0.0

EV/GP/RG

ABEO0.04

CYPHN/A

Ticker research

View ABEO research View CYPH research

Metric	ABEO Abeona Therapeutics Inc	CYPH Cypherpunk Technologies Inc
Market & Valuation
Market Cap	$282M	$313M
Enterprise Value	$240M	$305M
Price	$4.94	$2.94
P/E Ratio	N/A	N/A
P/S Ratio	11.03x	217.68x
EV/Sales	9.42x	0.00x
EV/EBITDA	3.95x	0.00x
P/B Ratio	2.25x	2.34x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.95x	-8.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	26.20x
Forward P/S (NTM)	3.20x	6.06x
Revenue & Growth
Revenue (TTM)	$26M	$0
Revenue Growth (YoY)	6280.0%	N/A
Forward Rev Growth	131.0%	155.2%
Profitability
Gross Margin (TTM)	67.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-316.6%	0.0%
Net Margin (TTM)	-246.4%	0.0%
FCF Margin (TTM)	-319.5%	N/A
Net Income (TTM)	$-63M	$-877K
FCF (TTM)	$-82M	$-35M
EPS (TTM)	-$1.10	-$0.00
ROE (TTM)	-4169.0%	-92.0%
ROA (TTM)	-3036.0%	-87.0%
ROIC (TTM)	-3719.0%	-92.0%
Financial Health
Cash	$56M	$8M
Debt	$15M	$0
Net Cash/Debt	$41M	$8M
Current Ratio (TTM)	6.63x	79.19x
Quick Ratio (TTM)	6.32x	78.88x
Debt/Equity (TTM)	0.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	1.13
52W Performance	-10.8%	292.0%
YTD Performance	-7.0%	160.2%
% from 52W High	-35.4%	-29.8%
% from 52W Low	23.5%	648.1%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.02x
FCF Yield (TTM)	-29.0%	-11.1%
Earnings Yield (TTM)	-22.3%	-0.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,960.5	0.0
EV/GP/RG	0.04	N/A
Ticker research	View ABEO research	View CYPH research